EISENBERG, Germany, Dec. 17, 2013 /CNW/ - A new study that was recently
published in the renowned Journal of Plastic Dermatology confirms once
again the therapeutic efficiency of thymus peptides against hair loss.
Telogen effluvium (TE) and androgenetic alopecia (AGA) are the main
causes of hair loss. Investigations to date found a proven clinical
effect [1-2] with synthetic thymus peptides in both AGA and chronic TE.
Study design and result
The objective of the investigation is to test the effectiveness and
cosmetic acceptance of thymus peptides with a low molecular weight (GKL
factor) in the first phases of AGA and in TE over six months. A thymus
peptide serum and a shampoo based on synthetic thymus peptides were
The study was carried out with 366 patients (m/f) with chronic TE and
first AGA stages.
The product used in the study achieved good clinical reaction with a
slowing of hair loss and stimulation of hair growth. At 98% of all 364
pull-test persons a decrease in hair loss could be observed. The
treatment was also able to improve typical symptoms that often
accompany these forms of illness, such as erythemes, itching and
seborrhoea. Positive cosmetic acceptance / tolerance was recorded in
98% of the cases.
Sources and bibliography
Barbareschi M, Arena N et al.: Multicentric study of the effects of
topical lotion and shampoo containing synthetic thymus peptides on
androgenetic alopecia and chronic telogen effluvium in women and men.
Journal of Plastic Dermatology. 2013: Vol.9 (2)
N. Meier: Thymic Peptides Differentially Modulate Human Hair Follicle
Growth. Journal of Investigative Dermatology (2012)
Donne Dermatologhe Italia (DDI). Clinical Investigation of the effects
of topical lotion and shampoo containing synthetic thymus peptides on
androgenetic and chronic telogen effluvium in women. J Plastic Dermatol
SOURCE: Vita-Cos-Med Klett-Loch GmbH
For further information:
Vita-Cos-Med Klett-Loch GmbH
Jan Korting Rontgenstr. 11
67304 Eisenberg / Germany